Research has concluded that the US will experience 500,000 fewer births in 2021, as couples choose not to have children because of the coronavirus fallout.
The findings by the Brookings Institute were published last week in the Wall Street Journal, which noted that there will be “between 300,000 to 500,000 fewer births in the U.S. next year, compared with a drop of 44,172 last year.”
The numbers equate to a 13% drop from the 3.8 million babies born in 2019.
The “analysis, partly based on what happened following the 2007-2009 recession, is that weaker job prospects equate to fewer births,” the report further notes.
The Serum Institute of India (SII), the world’s largest vaccine manufacturer, has gone on the offensive after a participant in its coronavirus vaccine trial sued the firm, alleging he suffered serious side effects from the jab.
In a countersuit, SII has demanded Rs 100 crore ($13.5 million USD) from the volunteer for his “malicious and misconceived” allegation that Covishield, a version of the AstraZeneca-Oxford University Covid-19 jab, led to a medical episode.
In a statement, the company said it was “sympathetic with the volunteer’s medical condition” but that there is “absolutely no correlation with the vaccine trial and the medical condition of the volunteer.” The Pune-based drug manufacturer stressed that the volunteer was “specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent,” but the individual “still chose to go public and malign the reputation” of SII.
As it turns out, the number of Chinese citizens who have received an experimental COVID-19 vaccine is much larger than the West probably realized.
According to SCMP, nearly 1 million Chinese, including troops on peacekeeping missions in coronavirus hotspots, have been given an experimental COVID-19 vaccine developed by the state-owned Sinopharm under the government’s emergency-use scheme.
So much for those international scientific standards: China has officially surpassed Russia in the vaccination race, as public health authorities in both countries are using vaccines that are still undergoing clinical trials. And according to Liu Jingzhen, the chairman of China’s Sinopharm, there has not been a single case of a “serious adverse event” (ie somebody getting seriously ill, or dying, because of the virus) despite the nearly 1 million infections.
While the lying, treasonous mainstream media is telling us all that covid-19 vaccines are perfectly safe and “95% effective” — and this lie is being repeated by PJ Media, Breitbart and other so-called “conservative” news publishers — the UK government has posted a bid and an award contract notice, seeking an Artificial Intelligence (AI) system that can process the expected flood of covid-19 vaccine injuries and side effects.
The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed.
Further in the document, the MHRA describes an “extreme urgency under Regulation 32(2)(c) related to the release of a Covid-19 vaccine” and says that the expected flood of covid-19 vaccine adverse reactions will overwhelm its current “legacy systems.”
Bill Gates is building something that we call the Human Implantable Quantum Dot Microneedle Vaccination Delivery System, and it is composed of multiple things. I want to draw your attention to one component, the quantum dot microneedles that will deliver the vaccines, and a very, very unique biochemical that makes it all work. If you’re standing up while reading this, you might want to sit down. Today we bring you ‘near infrared bioluminescence enzyme luciferase’ which is the chemical that will make the quantum dot vaccination readable through a special mobile device app. That’s right, the enzyme that will light up Bill Gates Human Implantable Quantum Dot Microneedle Vaccination Delivery System is called Luciferase, that’s what makes the vaccination readable long after the victim has been injected. Luciferase.
Bill Gates is building something that we call the Human Implantable Quantum Dot Microneedle Vaccination Delivery System, and it needs an enzyme called Luciferase in order to make it work. Remove the word ‘human’ and it becomes 666.
The parliamentary hearing period for a proposed new law giving the government extended powers to respond to epidemics expires today.
The new ‘epidemic law’ (epidemilov) would replace an emergency law passed in the spring which gave the government extended powers to intervene in society in order to fight the Covid-19 pandemic.
As well as enforcing quarantine measures, the existing law empowers the authorities prohibit access to public institutions, supermarkets and shops, public and private nursing homes and hospitals, and also to impose restrictions on access to public transport.
The end may be near for the pestilence that has haunted the world this year. Good news is arriving on almost every front: treatments, vaccines, and our understanding of this coronavirus.
Pfizer and BioNTech have announced a stunning success rate in their early Phase 3 vaccine trials—if it holds up, it will be a game changer. Treatments have gotten better too. A monoclonal antibody drug—similar to what President Donald Trump and the former Governor Chris Christie received—just earned emergency-use authorization from the FDA. Dexamethasone—a cheap, generic corticosteroid—cut the death rate by a third for severe COVID-19 cases in a clinical trial.
Doctors and nurses have much more expertise in managing cases even in using nonmedical interventions like proning, which can improve patients’ breathing capacity simply by positioning them facedown. Health-care workers are also practicing fortified infection-control protocols, including universal masking in medical settings
Walmart beginning Saturday is resuming monitoring and counting the number of customers entering its stores, to make sure it doesn’t exceed capacity limits, as coronavirus cases surge at record rates across the country.
Dating back to April, Walmart has been restricting the number of people in its big-box stores to not exceed five customers per every roughly 1,000 square feet, or about 20% of a store’s capacity. Those levels can also vary based on local mandates, the company said.
For a period of time, however, the biggest retailer in the United States had stopped physically counting people as they came inside and left.